共 50 条
- [1] Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey Allergy, Asthma & Clinical Immunology, 13
- [2] Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2017, 13